NCT00360724View on ClinicalTrials.gov

Duloxetine for Chronic Depression: a Double-blind Study

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2013

Conditions
Dysthymic DisorderDepressive Disorder NOS
Interventions
DRUG

Duloxetine (Cymbalta)

duloxetine medication up to dose of 120 mg/day

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

New York State Psychiatric Institute

OTHER

NCT00360724 - Duloxetine for Chronic Depression: a Double-blind Study | Biotech Hunter | Biotech Hunter